Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

dna Communications

- PMLiVE

Newron Pharma appoints commercial affairs VP

Dennis Dionne brings expertise from J&J and Novartis

- PMLiVE

Ipsen’s chief scientific officer steps down

Dr Claude Bertrand will be replaced ad interim by Alexandre Lebeaut

- PMLiVE

AstraZeneca appoints head of oncology

Dr Jamie Freedman joins from AZ subsidiary MedImmune

- PMLiVE

Former AZ oncology head joins Innate Pharma

Dr Mondher Mahjoubi becomes chairman of the executive board at the French biotech

- PMLiVE

Voyager Therapeutics appoints chief financial officer

Jane Pritchett Henderson joins the gene therapy specialist

- PMLiVE

BMS names chairman of the board

Giovanni Caforio to succeed Lamberto Andreotti on 2 May

- PMLiVE

uniQure appoints chief executive officer

Matthew Kapusta takes up the lead role in a permanent capacity

Bayer promotes Robert LaCaze

He becomes EVP of new oncology strategic business unit

- PMLiVE

Merck & Co’s Dr Daniel Pascheles joins Molekule Consulting

He becomes the biopharma services provider’s CEO

Eric Cornut appointed EFPIA interim director general

Steps into the role as Richard Bergström leaves the association

Actinium appoints director of clinical operations

Gregory Bergonio brings experience from Novartis

- PMLiVE

Robocath appoints CEO

Pascal Guy promoted at medical robotics start-up

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links